Key Takeaways
- AMTZ has launched the BRICS BioDesign Centre to promote medical technology innovation across BRICS nations.
- The initiative connects researchers, institutions, and industry partners to accelerate the development of healthcare solutions.
- Supported by key organizations, the programme aims to enhance the accessibility of medical technologies in emerging economies.
New Initiative for Medical Technology Innovation
Andhra Pradesh MedTech Zone (AMTZ) has inaugurated the BRICS BioDesign Centre in Visakhapatnam, designed to drive innovation in medical technology within BRICS countries. This initiative aims to facilitate the transition of healthcare innovations from early-stage concepts to viable market solutions.
Dr. Jitendra Sharma, MD & Founder CEO of AMTZ, highlighted the programme’s focus on creating partnerships that bridge the gap from scientific research to market delivery, ultimately benefiting patients. Collaborators include esteemed organizations such as the Office of the Principal Scientific Adviser to the Government of India, the Federation of Indian Chambers of Commerce and Industry (FICCI), and the Science & Technology Cluster.
Located at The Atrium, the BRICS BioDesign Centre serves as a collaborative hub integrating capabilities in clinical research, engineering, design, and prototyping. This platform aims to foster synergy among researchers, healthcare professionals, and industry stakeholders across BRICS nations.
The official launch on September 11 featured the signing of a Memorandum of Agreement among participating institutions, including the University of Cape Town in South Africa, Sechenov University in Russia, and Brazil’s Society of Biomedical Engineering (SBEB). This partnership is poised to combine scientific talent and BioDesign intelligence to effectively address healthcare challenges.
Professor Ajay Kumar Sood, Principal Scientific Adviser to the Government of India, expressed confidence in the programme’s potential to create a lasting innovation platform, serving both BRICS and other emerging economies. The BRICS BioDesign initiative specifically aims to support the development and adoption of accessible medical technologies, facilitating co-development, investment, and market access for healthcare innovations.
By creating structured pathways for collaboration, this initiative plans to significantly enhance the accessibility of medical technologies, propelling them from the prototype phase into real-world applications that can improve healthcare outcomes in emerging markets.
The content above is a summary. For more details, see the source article.
